Genomes and Genes

Species

Emmanuel Normant

Summary

Affiliation: Infinity Pharmaceuticals
Country: USA

Publications

  1. doi request reprint The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivo
    Mark Douglas
    Infinity Pharmaceuticals, 780 Memorial Drive, Cambridge, MA 02139, USA
    Mol Cancer Ther 8:3369-78. 2009

Collaborators

  • Mark Douglas
  • Thomas T Tibbits
  • Kip West
  • Melissa M Pink
  • James R Porter
  • Vito J Palombella
  • Jie Ge
  • Christian C Fritz
  • Julian Adams
  • Andrew A Wylie
  • Kurtis Biggs
  • Michael Curtis
  • Alice R Lim

Detail Information

Publications1

  1. doi request reprint The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivo
    Mark Douglas
    Infinity Pharmaceuticals, 780 Memorial Drive, Cambridge, MA 02139, USA
    Mol Cancer Ther 8:3369-78. 2009
    ..Our results suggest that NQO1 activity is not a determinant of IPI-504 activity in vivo and, therefore, unlikely to become an important resistance mechanism to IPI-504 in the clinic...